Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
Clinical trial NCT04221542 · RECRUITING
Trial details
- NCT number
- NCT04221542
- Sponsor
- Amgen
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-04
- Primary completion
- 2030-03-22
- Enrollment
- 479
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.